Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(50.0%)
Phase 3
1(50.0%)
2Total
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02564705Completed

Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis

Role: lead

NCT01597518Phase 2Terminated

Riluzole in Spinal Cord Injury Study

Role: lead

NCT01257828Phase 3Completed

Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)

Role: lead

NCT00285337Completed

Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy

Role: lead

NCT00266929Completed

Treatment of Type II Odontoid Fractures Among the Elderly

Role: lead

NCT00634426Completed

Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression

Role: lead

All 6 trials loaded